Expression of platelet-derived endothelial cell growth factor in non-small cell lung carcinomas: Relationship to various biological factors

International Journal of Oncology

Volumn 13, Issue 5, 1998, Pages 975-979

  Volm, Manfred ^a   Mattern, Jürgen ^a   Koomägi, Reet ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Angiogenic factors; Immunohistochemistry; Non small cell lung carcinomas; PD ECGF; Proliferative activity; Proto oncogenes; Response to doxorubicin

Indexed keywords

CYCLIN A; DOXORUBICIN; PLATELET DERIVED ENDOTHELIAL CELL GROWTH FACTOR; PROTEIN P53; RAS PROTEIN; VASCULOTROPIN;

ADULT; ARTICLE; CELL CYCLE G1 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; CONTROLLED STUDY; DRUG SENSITIVITY; FLOW CYTOMETRY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CARCINOMA, NON-SMALL-CELL LUNG; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; ENDOTHELIAL GROWTH FACTORS; HUMANS; LUNG NEOPLASMS; LYMPHOKINES; MIDDLE AGED; NEOPLASM PROTEINS; THYMIDINE PHOSPHORYLASE; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 0031732927     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.5.975     Document Type: Article

References (23)

1. Moghaddam A and Bicknell R: Expression of platelet-derived endothelial cell growth factor in Escherichia call and confirmation of its thymidine phosphorylase activity. Biochemistry 31: 12141-12146, 1992.
2. Ishikawa F, Miyazono K, Hellman U, Dexler H, Wernstedt C, Hagiwara K, Usuki K, Takaku F, Risau W and Weldin CH: Identification of angiogenic activity and the cloning and expressing of platelet-derived endothelial cell growth factor. Nature 338: 557-562, 1989.
3. Mizutani Y, Okada Y and Yoshida O: Expression of platelet-derived endothelial cell growth factor in bladder carcinoma. Cancer 79: 1190-1194, 1997.
4. Koukourakis MI, Giatromanolaki A, O'Byrne KJ, Comley M, Whitehouse RM, Talbot DC, Gatter KC and Harris AL: Platelet-derived endothelial cell growth factor expression correlates with tumour angiogenesis and prognosis in non-small cell lung cancer. Br J Cancer 75: 477-481, 1997.
5. Imazono Y, Takebayashi Y, Nishiyama K, Akiba S, Miyadera K, Yamada Y, Akiyama S and Ohi Y: Correlation between thymidine phosphorylase expression and prognosis in human renal cell carcinoma. J Clin Oncol 15: 2570-2578, 1997.
6. Takebayashi Y, Akiyama S, Akiba S, Yamada K, Miyadera K, Sumizawa T, Yamada Y, Murada F and Aikou T: Clinopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinoma. J Natl Cancer Inst 88: 1110-1117, 1996.
7. Iltzsch MH, Koumi MH and Cha S: Kinetic studies of thymidine phosphorylase from mouse liver. Biochemistry 24: 6799-6807, 1985.
8. Krenitsky TA, Koszalka GW and Tuttle JV: Purine nucleoside synthesis, an efficient method employing nucleoside phosphorylases. Biochemistry 20: 3615-3621, 1981.
9. Sotos GA, Grogan L and Allegra CJ: Preclinical and clinical aspects of biomodulation of 5-fluorouracil. Cancer 20: 11-49, 1994.
10. Patterson A, Zhang H, Moghaddam A, Bicknell R, Talbot DC, Stratford IJ and Harris AL: Increased sensitivity to the pro-drug 5′-deoxy-5-fluorouridine and modulation of 5′-fluoro-2′-deoxyuridine sensitivity in MCF-7 cells transfected with thymidine phosphorylase. Br J Cancer 72: 669-675, 1995.
11. Koomägi R, Mattern J and Volm M: Up-regulation of resistance-related proteins in human lung tumors with poor vascularization. Carcinogenesis 16: 2129-2133, 1995.
12. Volm M, Koomägi R, Mattern J and Stammler G: Angiogenic growth factors and their receptors in non-small cell lung carcinomas and their relationships to drug resistance in vitro. Anticancer Res 17: 99-104, 1997.
13. World Health Organization: Histological typing of lung tumors. Tumori 6: 553-572, 1981.
14. Carr D and Mountain CF: Staging lung cancer. In: Lung Cancer. Clinical diagnosis and treatment. Straus MJ (ed). Grune and Stratton, New York, pp 151-161, 1977.
15. Nishida M, Hino A, Mori K, Matsumoto T, Yoshikubo I and Ishitsuka H: Preparation of anti-human phosphorylase monoclonal antibodies useful for detecting the enzyme levels in tumor tissues. Biol Pharm Bull 19: 1407-1411, 1996.
16. Volm M, Mattern J and Samsel B: Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein, and glutathione-S-transferase π in human lung tumors. Cancer 71: 3181-3187, 1993.
17. Krehan A, Lorenz P, Plana-Coll M and Pyerin W: Interaction sites between catalytic and regulatory subunits in human protein kinase CK2 holoenzymes as indicated by chemical cross-linking and immunological investigations. Biochemistry 35: 4966-4975, 1996.
18. Group of Sensitivity Testing of Tumors (KSST): In vitro short-term test to determine the resistance of human tumors to chemotherapy. Cancer 48: 2127-2135, 1981.
19. Volm M, Kaufmann M and Mattern J: Results obtained using a short-term nucleotide assay and clinical correlations. In: Human Tumor Drug Sensitivity Testing in vitro. Dendy PP and Hill BT (eds). Academic Press, London, pp251-258, 1983.
20. Toi M, Inada K, Hoshima S, Suzuki, H, Kondo S and Tominaga T: Vascular endothelial growth factor and platelet-derived endothelial cell growth factor are frequently coexpressed in highly vascularized human breast cancer. Clin Cancer Res 1: 961-964, 1995.
21. Moghaddam A, Zhang H-T, Fan T-PD, Hu, DE, Lees VC, Turley H, Fox SB, Gatter KC, Harris AL and Bicknell R: Thymidine phosphorylase is angiogenic and promotes tumor growth. Proc Natl Acad Sci USA 92: 998-1002, 1995.
22. Toi M, Hoshima S, Taniguchi T, Yamamoto Y, Ishitsuka H and Tominaga T: Expression of platelet-derived endothelial cell growth factor thymidine phosphorylase in human breast cancer. Int J Cancer (Pred Oncol) 64: 79-82, 1995.
23. Haraguchi M, Furukawa T, Sumizawa T and Akiyama S: Sensitivity of human KB cells expressing platelet-derived endothelial cell growth factor to pyrimidine antimetabolites. Cancer Res 53: 5680-5682, 1993.